Podcast Episodes
Back to Search
$920M NPV Transforms Great Atlantic Project | Atlas Salt (TSXV: SALT) | The Watchlist E7
Episode 7
In this episode of The Watchlist, Atlas Salt Inc. (TSXV: SALT | OTCQB: REMRF | FSE: 9D00) shares details of its updated feasibility study for the Gre…
1 year ago
BC Gold-Copper: Grid Battery Metals' Next Phase in Prolific Omineca Region | Grid Battery Metals (CELL) | The Watchlist E6
Episode 6
Grid Battery Metals (TSXV: CELL | OTCQB: EVKRF | FRA: NMK2) updates listeners on its Gold-Copper Property in the prolific Omineca mining region of no…
1 year ago
Cash Flow Today, Discovery Tomorrow: ESGold (CSE:ESAU) | The Watchlist E5
Episode 5
In this episode of The Watchlist, host Ricki Lee is joined by ESGold (CSE:ESAU | OTCQB:ESAUF) CEO Gordon Robb to discuss the company's unique "cash f…
1 year, 1 month ago
A $250M Catalyst De-Risks Path to Production | Highland Copper (TSXV: HI) | The Watchlist E4
Episode 4
In this episode, Highland Copper (TSXV: HI) CEO Barry O'Shea joins The Watchlist to discuss two major de-risking milestones for the Copperwood projec…
1 year, 1 month ago
PharmAla Biotech Creates U.S. MDMA Hub, De-Risking Clinical Trials | PharmAla Biotech (CSE:MDMA) | The Watchlist E3
Episode 1
In this episode of The Watchlist, we're joined by Nicholas Kadyshr, CEO of PharmAla Biotech (CSE:MDMA). He discusses the company's major strategic mo…
1 year, 1 month ago
Accsys (LSE:AXS) CEO on 55% North American Sales Growth & Strategic Expansion | The Watchlist E2
Episode 2
Accsys (LSE:AXS) has released a new trading update highlighting significant growth and strategic progress. In this episode, we explore the company's …
1 year, 1 month ago
ImmuPharma (LON:IMM) CEO on P140 Autoimmune Breakthrough & Investment Outlook | The Watchlist E1
Episode 1
In Episode 1 of The Watchlist, we sit down with ImmuPharma CEO Tim McCarthy for a deep dive into their groundbreaking autoimmune treatment, P140, and…
1 year, 1 month ago